Hospitals primarily use urine immunoassay tests to screen for drugs. These automated tests produce results quickly, often within an hour, making them the standard tool in emergency departments and inpatient settings. Depending on the situation, hospitals may also draw blood, test other biological samples, or send specimens out for more advanced confirmation testing.
How Immunoassay Screening Works
The workhorse of hospital drug testing is the urine immunoassay. It works by using antibodies that react to specific drug classes. If the concentration of a substance in your urine meets or exceeds a preset threshold, the test flags it as positive. Results are reported as simply positive or negative, not as an exact measurement.
These tests are popular in hospitals because they’re fast and easily automated. But speed comes with tradeoffs. Immunoassays can only identify broad drug classes rather than pinpointing the exact substance. For example, a positive result for “opiates” doesn’t tell the doctor whether you took morphine, codeine, or heroin. And some drugs within a class are poorly detected. Certain benzodiazepines and synthetic opioids can slip through entirely, producing a false negative even when the drug is present.
What a Standard Panel Covers
Hospitals typically order panels that screen for anywhere from 5 to 12 drug classes at once. A common 10-drug panel includes:
- Amphetamines (including methamphetamine)
- Barbiturates
- Benzodiazepines (such as alprazolam, lorazepam, and diazepam)
- Cocaine (detected through its metabolite)
- Marijuana (THC)
- Methadone
- Opiates (morphine, codeine, hydrocodone, hydromorphone)
- Oxycodone/oxymorphone
- Phencyclidine (PCP)
- Propoxyphene
The panel also checks urine pH and creatinine levels to flag samples that may have been diluted or tampered with. Emergency physicians can also order additional individual tests based on what they suspect, but the panel above covers the most commonly encountered substances.
Where Fentanyl Fits In
Standard immunoassay panels have historically missed fentanyl. Because fentanyl is a fully synthetic opioid, it doesn’t trigger the traditional “opiates” screen, which is designed to detect drugs derived from the opium poppy like morphine and codeine. This has been a significant blind spot during the fentanyl crisis.
Many hospitals now add a separate fentanyl-specific test to their orders. The federal government recently updated its mandatory drug testing guidelines to include fentanyl and its metabolite norfentanyl, with an extremely low cutoff of just 1 ng/mL in urine. That threshold is far more sensitive than the cutoffs for other drugs, reflecting fentanyl’s potency at tiny doses. Still, whether fentanyl testing is routine at a given hospital depends on that facility’s protocols. In some places, it must be specifically requested.
Detection Cutoffs That Determine a Positive
Each drug class has a concentration threshold below which the test reports negative, even if some amount of the substance is present. The standard cutoffs for initial screening are:
- THC (marijuana): 50 ng/mL
- Cocaine: 300 ng/mL
- Opiates: 300 ng/mL
- Amphetamines: 1,000 ng/mL
- PCP: 25 ng/mL
- Benzodiazepines: 100 ng/mL
- Barbiturates: 300 ng/mL
- Methadone: 300 ng/mL
These thresholds mean that recent, low-level exposure can produce a negative result. The amphetamine cutoff is particularly high at 1,000 ng/mL, which can miss smaller doses. On the other hand, the marijuana threshold is relatively low, and THC’s fat solubility means it accumulates in the body over time. Daily marijuana users can test positive for up to a month after their last use, while occasional users typically clear it within a week.
How Long Each Substance Stays Detectable
Detection windows in urine vary widely by substance and how frequently you use it:
- Alcohol: 10 to 12 hours (up to 48 hours with specialized metabolite testing)
- Marijuana: 1 to 30 days, depending on frequency of use
- Cocaine: 1 to 4 days
- Heroin: 2 to 3 days
- Morphine: 2 to 5 days
- Codeine: 2 to 4 days
Blood tests have much shorter windows, generally 1 to 36 hours for most substances, which makes them useful when the hospital needs to know what’s in your system right now. Hair testing can detect use going back up to 90 days, but hospitals rarely use hair tests in acute care because results take too long.
False Positives From Common Medications
Immunoassays are prone to cross-reactivity, meaning substances with a similar chemical structure to the target drug can trigger a positive. This is one of their most well-known limitations. A range of everyday over-the-counter and prescription medications have been linked to false positives.
Amphetamine false positives are the most frequently reported and can be triggered by bupropion (an antidepressant), certain antihistamines like brompheniramine and diphenhydramine, the cough suppressant dextromethorphan, and even over-the-counter nasal inhalers. False positives for opioids have been associated with ibuprofen, naproxen, dextromethorphan, and the antacid ranitidine. The antipsychotic quetiapine and the antidepressants sertraline, trazodone, and venlafaxine have also triggered false results across multiple drug categories.
This is why a positive immunoassay screen is considered presumptive, not definitive. If the result matters for clinical decisions or has legal implications, hospitals send the sample for confirmation testing.
Confirmatory Testing With Mass Spectrometry
When a hospital needs to verify a positive screen, the gold standard is gas chromatography-mass spectrometry (GC-MS) or its newer cousin, liquid chromatography-mass spectrometry (LC-MS). These instruments physically separate and identify individual molecules in the sample, eliminating the cross-reactivity problem that plagues immunoassays.
Confirmatory testing can pinpoint exactly which drug is present and at what concentration. It’s far more accurate but also more expensive and time-consuming, so hospitals reserve it for cases where precision matters. In emergency medicine, doctors often act on the immunoassay result combined with your symptoms and history rather than waiting for confirmation.
Clinical Testing vs. Forensic or Employment Testing
Hospital drug tests serve a fundamentally different purpose than the tests used for employment screening, court proceedings, or law enforcement. In a clinical setting, the customer is your doctor, and the goal is making timely treatment decisions. There’s no formal chain of custody for the sample, and if the result is unclear, the hospital can simply collect another specimen and retest.
Forensic and workplace testing operates under strict protocols. Samples follow a documented chain of custody from collection to analysis. Results must be defensible in legal proceedings, and the scientist who performed the analysis may be called to testify. Federal workplace testing follows mandatory guidelines set by the Department of Health and Human Services, which dictate exactly which drugs to test for and what cutoff levels to use. Hospital clinical tests aren’t bound by those same rules, giving physicians flexibility to order whatever panel best fits the patient’s situation.
How Hospitals Test Newborns
When there’s concern about prenatal drug exposure, hospitals can test newborns using several sample types: urine, blood, meconium (the baby’s first stool), hair, or umbilical cord tissue. Each has different strengths.
Urine and blood provide the fastest results and are screened with the same immunoassay technology used in adults. Urine is generally preferred because it can be collected noninvasively with a bag specimen. However, these samples only reflect very recent exposure.
Meconium begins forming during the second trimester, so a positive meconium test typically reflects drug exposure over the last month or more of pregnancy. This makes it more useful for identifying a pattern of use rather than a single instance. It’s also considered more reliable than urine because collection is more straightforward. If meconium isn’t available, umbilical cord tissue offers a similar window, though the exact lookback period is less well established. Hair testing can extend the detection window into the third trimester, but many newborns don’t have enough hair growth for an adequate sample. As with adult testing, any positive screen should be confirmed with mass spectrometry before clinical or legal conclusions are drawn.